|
Press Releases |
|
 |
|
Tuesday, August 29, 2023 |
|
Malaysian Genomics Unveils Strategic Advances in Biopharmaceuticals |
Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, recorded a revenue of RM2.23 million for the 4th quarter ended 30 June 2023. This represents a decrease from RM6.33 million in the corresponding quarter of the preceding year, owing to a deliberate pivot from vaccines to cell and gene therapy products, focusing more on genetic screening initiatives. more info >> |
|
Monday, May 15, 2023 |
|
Malaysian Genomics Inks Agreement in Expansion to Bangladesh |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced a strategic cooperation agreement (SCA) with Toticell Limited for the distribution of the Group's products in Bangladesh. more info >> |
|
Monday, February 27, 2023 |
|
Malaysian Genomics to Boost Play on the Football Pitch |
Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, is collaborating with KL City FC Sdn Bhd (KLCFC), the manager of the KL City FC football club, on the deployment of the Group's genetic screening tests for peak athletic performance. more info >> |
|
Friday, February 24, 2023 |
|
Malaysian Genomics Pivots to Biopharmaceuticals for Growth |
Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today announced that the Group recorded a revenue of RM1.64 million for the second quarter ended 31 December 2022 (2Q 2023). This amount is down from RM7.63 million in 2Q 2022, as the Group moved its focus from vaccines to biopharmaceuticals. more info >> |
|
Malaysian Genomics to Collaborate on Cannabinoid R&D |
Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today announced that the Group has entered into a strategic collaboration with Kensana Health Canada and MAHSA University for the research and development (R&D) of phytopharmaceutical and biotechnology products that can lead to commercialisation. more info >> |
|
Wednesday, February 22, 2023 |
|
Malaysian Genomics to Offer World's First DNA-Driven Fertility Test |
Malaysian Genomics Resource Centre Bhd, a leading genomics and biopharmaceutical specialist, today announced that the Group has signed a strategic collaboration agreement with Divine Genes Sdn Bhd to collaborate on business opportunities in relation to the improvement and international distribution of genetic tests for reproductive health. more info >> |
|
Monday, January 9, 2023 |
|
Malaysian Genomics Explores R&D Collaboration with SIRIM |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce a strategic cooperation with SIRIM Berhad, to explore the commercialisation of joint research and development (R&D) projects in the medical and biotechnology fields. more info >> |
|
Wednesday, November 23, 2022 |
|
Malaysian Genomics Sees Rise in Profit Margins for 1Q |
Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today reported a revenue of RM3.81 million for the first quarter ended 30 September 2022 (1Q 2023) versus a revenue of RM9.32 million in 1Q 2022, as the Group refocuses on immunotherapy and cell therapies under the biopharmaceutical business and pushes for organic growth of its genetic screening business. more info >> |
|
Wednesday, October 26, 2022 |
|
Malaysian Genomics Signs Strategic Collaboration Agreement for Expansion in the UAE |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced the signing of a Strategic Collaboration Agreement (SCA) outlining partnerships to market and distribute the Group's Dtect(R) range of genetic screening services in the United Arab Emirates (UAE). more info >> |
|
Wednesday, October 12, 2022 |
|
Malaysian Genomics Signs Agreement with National Institutes of Health to Explore Research Opportunities |
MGRC Therapeutics Sdn Bhd (MGRC-T), a wholly-owned subsidiary of Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, has entered into a cooperation agreement with the National Institutes of Health, Malaysia (NIH), providing a framework for collaboration between the two parties in medical research pertaining to genomics and biopharmaceuticals. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
AI產業延續高景氣 明略科技講出企業級「DeepSeek+Manus」好故事
Apr 24, 2025 10:50 HKT/SGT
|
|
|
AI产业延续高景气 明略科技讲出企业级「DeepSeek+Manus」好故事
Apr 24, 2025 10:44 HKT/SGT
|
|
|
MHI Thermal Systems Wins German Red Dot Design Award 2025
Apr 24, 2025 10:11 JST
|
|
|
Waterloo Startup Axibo AI Secures $12M to Pioneer 'Made in Canada' Humanoids
Apr 24, 2025 09:10 HKT/SGT
|
|
|
ULVAC Develops Dilution Refrigerator for Quantum Computers
Apr 24, 2025 9:30 JST
|
|
|
EdgePoint Towers advances renewable energy integration in telecommunications with first solar hybrid deployment
Apr 24, 2025 07:46 HKT/SGT
|
|
|
Batch Bicycles and Hyatt Place Zhuhai jointly organized An Exhalating Cycling Event in Macau
Apr 24, 2025 07:33 HKT/SGT
|
|
|
百琦自行車與珠海橫琴凱悅酒店聯合舉辦騎行澳門活動
Apr 23, 2025 18:32 HKT/SGT
|
|
|
百琦自行车与珠海横琴凯悦酒店联合举办骑行澳门活动
Apr 23, 2025 18:23 HKT/SGT
|
|
|
海通恆信:創新不息 驅動新質生產力發展行穩致遠
Apr 23, 2025 16:33 HKT/SGT
|
|
|
海通恒信:创新不息 驱动新质生产力发展行稳致远
Apr 23, 2025 16:19 HKT/SGT
|
|
|
アリックスパートナーズ、中国自動車市場の最新調査を発表
Apr 23, 2025 13:00: JST
|
|
|
裝機及發電雙增超47% 北京能源國際領跑清潔能源賽道
Apr 23, 2025 11:45 HKT/SGT
|
|
|
装机及发电双增超47% 北京能源国际领跑清洁能源赛道
Apr 23, 2025 11:28 HKT/SGT
|
|
|
Fujitsu expands strategic collaboration with Supermicro to offer total generative AI platform
Apr 23, 2025 11:55 JST
|
|
|
|
More News >> |
|
|
|
|
|